Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Details
Original language | English |
---|---|
Pages (from-to) | 2309-2313 |
Number of pages | 5 |
Journal | Leukemia |
Volume | 37 |
Issue number | 11 |
Publication status | Published - Nov 2023 |
Peer-reviewed | Yes |
External IDs
PubMedCentral | PMC10624604 |
---|---|
Scopus | 85171658935 |
Keywords
Keywords
- Humans, Benzocycloheptenes, Leukemia, Myeloid, Acute/drug therapy, Myelodysplastic Syndromes/drug therapy, Triazoles